The Business Research Company’s 2026 market reports combine market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights to deliver research that is more actionable and strategically valuable.
Artificial Intelligence In Cardiology Market Value Projected To Grow At A 41.2% Compound Annual Growth Rate Through 2030
The artificial intelligence in cardiology market size has shown substantial growth in recent years. This market is set to expand from $2.72 billion in 2025 to $3.82 billion in 2026, achieving a compound annual growth rate (CAGR) of 40.7%. The market’s historic growth can be linked to the rising prevalence of cardiovascular disease, the early adoption of cardiac imaging software, the growth of wearable medical devices, a demand for faster diagnoses, and the expansion of digital healthcare infrastructure.
The artificial intelligence in cardiology market is projected for rapid expansion over the coming years, with its size expected to reach $15.19 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 41.2%. This anticipated growth is driven by factors such as the adoption of remote patient monitoring, AI-powered clinical decision support, tailored cardiology treatments, the integration of telecardiology platforms, and an increased emphasis on preventive cardiac care. Key trends during this period are expected to encompass AI-based cardiac imaging analysis, the rise of predictive cardiology analytics, the incorporation of wearable heart monitoring devices, automated arrhythmia detection, and the broadening of remote cardiac care solutions.
Evaluate The Artificial Intelligence In Cardiology Market Report Before You Buy With A Free Sample:
Artificial Intelligence In Cardiology Market Growth Driver Analysis For The 2026–2030 Forecast Period
The increasing prevalence of cardiovascular diseases is expected to stimulate the growth of artificial intelligence in the cardiology market moving forward. Cardiovascular diseases refer to all conditions that can affect the heart and blood vessels. In cardiology, AI is utilized to detect cardiovascular diseases by assisting with electrocardiogram (ECG) interpretation and helping to identify conditions like long QT syndrome and atrial fibrillation. Moreover, AI can process vast quantities of data from electronic health records, mobile health devices, and imaging information. For instance, in August 2025, according to the American Cancer Society, a US-based non-profit organization, a 90.0% increase in cardiovascular prevalence is anticipated between 2025 and 2050. Furthermore, in October 2024, data from the Centres for Disease Control and Prevention (CDC), a US-based federal health agency, showed that 919,032 people died from cardiovascular disease in the United States in 2023, representing 1 in every 3 deaths. Therefore, the substantial impact of cardiovascular diseases is driving the expansion of Artificial intelligence (AI) in Cardiology.
Artificial Intelligence In Cardiology Market Segmentation Breakdown: Primary And Secondary Categories
The artificial intelligence in cardiology market covered in this report is segmented –
1) By Component: Hardware, Software Solutions, Services
2) By Application: Cardiac Arrhythmia, Stroke, Ischemic Heart Disease Or Coronary Artery Disease (CAD), Other Applications
3) By End-Use: Lifescience Companies, Healthcare Payers, Healthcare Providers
Subsegments:
1) By Hardware: Imaging Devices, Wearable Devices, Diagnostic Equipment
2) By Software Solutions: Cardiac Imaging Analysis Software, Predictive Analytics Tools, Patient Management Systems, Telemedicine Platforms
3) By Services: Consulting Services, Integration And Implementation Services, Maintenance And Support Services, Training And Education Services
Artificial Intelligence In Cardiology Market Industry Trends: New Developments From Leading Companies
Leading companies within the artificial intelligence in cardiology market are concentrating on strategic collaborations to transform heart research. These partnerships involve entities utilizing one another’s strengths and assets to attain shared advantages and achievements. An example is the announcement made in October 2023 by the Icahn School of Medicine at Mount Sinai, a US-based medical institution, regarding its collaboration with Japan’s Chiba Institute of Technology (CIT). This collaboration between the two universities aims to enhance understanding, prevention, and treatment of cardiovascular disease, alongside developing innovative approaches to address this worldwide health issue. Mount Sinai and CIT plan to jointly conduct global clinical studies incorporating artificial intelligence across various fields including interventional cardiology, heart failure, cardiac electrophysiology, cardiac imaging, and preventive cardiology. Furthermore, the research will address reducing gender and racial bias where artificial intelligence and cardiovascular research intersect, with the goal of improving patient care and outcomes.
Who Are The Top Competitors In The Artificial Intelligence In Cardiology Market?
Major companies operating in the artificial intelligence in cardiology market are Microsoft Corporation; International Business Machines Corporation; Siemens Healthineers; Koninklijke Philips; Ultromics Ltd; Bay Labs; Cleerly Inc.; RSIP Vision Ltd.; Idoven; Cardiologs Technologies Inc.; Viz.ai; Aidoc; Arterys Inc.; Zebra Medical Vision; AliveCor; DiA Imaging Analysis; Eko Health Inc.; Cardiomatics; UltraSight; Anumana Inc.; CardiAI Inc.; Caption Health Inc.; HeartFlow Inc.; iRhythm Technologies Inc.; Biofourmis Inc.
Access The Artificial Intelligence In Cardiology Market Report For Complete Segment-Level Analysis:
Which Region Leads The Artificial Intelligence In Cardiology Market, And Which Regions Are Covered?
North America was the largest region in the artificial intelligence in cardiology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence in cardiology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.
